Search

everythinglearnresearchcommunity

for

Search:↓

Deoxycholic acid effectively reduces double chin fat with temporary side effects and high patient satisfaction.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

A new staining method shows a special area in the hair's skin layer with lots of proteoglycans.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Blue light promotes hair growth by interacting with specific receptors in hair follicles.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Hair loss is more common in male Chinese college freshmen, and it's linked with rosacea but doesn't affect their quality of life.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Different tests are used to see how hair care products affect hair, and choosing the right test is important for accurate results.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

Different types of fibroblasts play various roles in both healthy and diseased tissues, and understanding them better could improve treatments for fibrotic diseases.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Silver nanoparticles coated with substances like PEG showed strong antibacterial effects and improved wound healing when used in hydrogels.

Estrogen therapy can reduce skin aging but has cancer risks.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Four natural compounds were found to promote hair growth effectively.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.